Audrey Emmanuelle Dugué

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

Paul Lesueur, Justine Lequesne, Jean‐Michel Grellard et al. · BMC Cancer · 2019 · 114 citations · Full text

O⁶‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation and low MGMT‐encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide

Emmanuèle Lechapt, Guénaëlle Levallet, Audrey Emmanuelle Dugué et al. · Cancer · 2012 · 87 citations · Full text

Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease

Joachim Alexandre, Éric Saloux, Audrey Emmanuelle Dugué et al. · Journal of Cardiovascular Magnetic Resonance · 2013 · 77 citations · Full text

Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

Dimitri Bellèvre, Cécile Fournier, O. Switsers et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 57 citations · Full text

Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in Relapsing-Remitting-Multiple Sclerosis patients at the earlier stage of the disease: A PET/MR study

Nathalie Derache, Blandine Grassiot, Florence Mézenge et al. · Multiple Sclerosis and Related Disorders · 2013 · 48 citations

Neurological Functioning, Neurological Disorder, Neurological Progress +9